The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT06066359
Brief Title: Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
First Submitted : September 27, 2023
First Submitted that Met QC Criteria : September 27, 2023
First Posted : October 4, 2023
Last Update Submitted that Met QC Criteria : March 27, 2024
Last Update Posted : March 29, 2024